| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.3 | 7e-20 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-10 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.29 | 3e-08 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.28 | 5e-08 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |